Pharmacological Treatments Available for Immune-Checkpoint-Inhibitor-Induced Colitis

Immune checkpoint inhibitor treatment has shown revolutionary therapeutic effects in various carcinomas. However, immune-related adverse events (irAE) following this treatment can sometimes lead to treatment discontinuation. One such frequently encountered adverse event is immune-related colitis (ir...

Full description

Bibliographic Details

Published in:	Biomedicines
Main Authors:	Sae Ohwada, Keisuke Ishigami, Noriyuki Akutsu, Hiroshi Nakase
Format:	Article
Language:	English
Published:	MDPI AG 2022-06-01
Subjects:	immune checkpoint inhibitor immune-related adverse events irAE colitis corticosteroid infliximab vedolizumab
Online Access:	https://www.mdpi.com/2227-9059/10/6/1334